Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Frontiers in Medicine
|
May 4, 2026
Horizon scanning at EMA: preparing for the medicines of the future
Patrícia Dias Correia, Valentina Cordo', Oriane Blanquie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2014
Cancer drug development and the evolving regulatory framework for companion diagnostics in the European union
Francesco Pignatti, Falk Ehmann, Robert Hemmings, et al.
Leukemia & Lymphoma
|
August 23, 2006
Detection of N-RAS and K-RAS in their active GTP-bound form in acute myeloid leukemia without activating RAS mutations
Falk Ehmann, Stefan Horn, Lizet Garcia-Palma, et al.
European Journal of Public Health
|
February 14, 2013
Modelling the risk-benefit impact of H1N1 influenza vaccines
Lawrence D Phillips, Barbara Fasolo, Nikolaos Zafiropoulous, et al.
Nature Reviews. Drug Discovery
|
February 2, 2013
Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective
Marc Maliepaard, Charity Nofziger, Marisa Papaluca, et al.
Clinical Pharmacology and Therapeutics
|
February 9, 2022
Biomarker Qualification at the European Medicines Agency: A Review of Biomarker Qualification Procedures From 2008 to 2020
Elisabeth Bakker, Natalie M Hendrikse, Falk Ehmann, et al.
Clinical Pharmacology and Therapeutics
|
October 28, 2025
A Fast Path from Innovation to Safe and Effective Medicines
Peter Arlett, Falk Ehmann, Ralf Herold, et al.
Nanomedicine (London, England)
|
May 10, 2013
Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines
Falk Ehmann, Kumiko Sakai-Kato, Ruth Duncan, et al.
Blood
|
October 25, 2012
Biosimilars: what clinicians should know
Martina Weise, Marie-Christine Bielsky, Karen De Smet, et al.
Nucleic Acid Therapeutics
|
January 4, 2024
Report of the European Medicines Agency Conference on RNA-Based Medicines
Falk Ehmann, Andreas Kuhn, Anna Maria Gerdina Pasmooij, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Frontiers in Medicine
|
May 4, 2026
Horizon scanning at EMA: preparing for the medicines of the future
Patrícia Dias Correia, Valentina Cordo', Oriane Blanquie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2014
Cancer drug development and the evolving regulatory framework for companion diagnostics in the European union
Francesco Pignatti, Falk Ehmann, Robert Hemmings, et al.
Leukemia & Lymphoma
|
August 23, 2006
Detection of N-RAS and K-RAS in their active GTP-bound form in acute myeloid leukemia without activating RAS mutations
Falk Ehmann, Stefan Horn, Lizet Garcia-Palma, et al.
European Journal of Public Health
|
February 14, 2013
Modelling the risk-benefit impact of H1N1 influenza vaccines
Lawrence D Phillips, Barbara Fasolo, Nikolaos Zafiropoulous, et al.
Nature Reviews. Drug Discovery
|
February 2, 2013
Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective
Marc Maliepaard, Charity Nofziger, Marisa Papaluca, et al.
Clinical Pharmacology and Therapeutics
|
February 9, 2022
Biomarker Qualification at the European Medicines Agency: A Review of Biomarker Qualification Procedures From 2008 to 2020
Elisabeth Bakker, Natalie M Hendrikse, Falk Ehmann, et al.
Clinical Pharmacology and Therapeutics
|
October 28, 2025
A Fast Path from Innovation to Safe and Effective Medicines
Peter Arlett, Falk Ehmann, Ralf Herold, et al.
Nanomedicine (London, England)
|
May 10, 2013
Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines
Falk Ehmann, Kumiko Sakai-Kato, Ruth Duncan, et al.
Blood
|
October 25, 2012
Biosimilars: what clinicians should know
Martina Weise, Marie-Christine Bielsky, Karen De Smet, et al.
Nucleic Acid Therapeutics
|
January 4, 2024
Report of the European Medicines Agency Conference on RNA-Based Medicines
Falk Ehmann, Andreas Kuhn, Anna Maria Gerdina Pasmooij, et al.
Page
of 2